Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecologic Surgical Procedures | 5 | 2024 | 64 | 1.880 |
Why?
|
| Vagina | 2 | 2024 | 196 | 1.020 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2024 | 70 | 0.850 |
Why?
|
| Robotic Surgical Procedures | 2 | 2024 | 194 | 0.820 |
Why?
|
| Genital Diseases, Female | 2 | 2018 | 30 | 0.780 |
Why?
|
| Morcellation | 2 | 2018 | 4 | 0.750 |
Why?
|
| Minimally Invasive Surgical Procedures | 4 | 2015 | 194 | 0.700 |
Why?
|
| Contraception | 3 | 2007 | 58 | 0.680 |
Why?
|
| Contraceptive Devices, Female | 2 | 2011 | 2 | 0.670 |
Why?
|
| Uterine Neoplasms | 4 | 2018 | 117 | 0.670 |
Why?
|
| Gynecology | 3 | 2014 | 127 | 0.620 |
Why?
|
| Leiomyoma | 3 | 2017 | 90 | 0.550 |
Why?
|
| Menstruation Disturbances | 2 | 2003 | 13 | 0.430 |
Why?
|
| Laparoscopy | 4 | 2018 | 501 | 0.390 |
Why?
|
| Nickel | 1 | 2011 | 22 | 0.380 |
Why?
|
| Ovarian Neoplasms | 2 | 2006 | 408 | 0.370 |
Why?
|
| Hysterectomy | 4 | 2018 | 185 | 0.360 |
Why?
|
| Radiography, Interventional | 1 | 2010 | 87 | 0.330 |
Why?
|
| Hypersensitivity | 1 | 2011 | 182 | 0.320 |
Why?
|
| Physicians | 2 | 2015 | 583 | 0.320 |
Why?
|
| Patient Participation | 1 | 2010 | 221 | 0.280 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 29 | 0.280 |
Why?
|
| Sterilization, Reproductive | 2 | 2003 | 6 | 0.270 |
Why?
|
| Dysgerminoma | 1 | 2006 | 5 | 0.270 |
Why?
|
| Luteal Phase | 1 | 2006 | 10 | 0.260 |
Why?
|
| Referral and Consultation | 1 | 2010 | 529 | 0.260 |
Why?
|
| Dermatitis | 1 | 2006 | 25 | 0.260 |
Why?
|
| Glomerulonephritis | 1 | 2006 | 73 | 0.260 |
Why?
|
| Sarcoidosis | 1 | 2006 | 61 | 0.250 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2015 | 13 | 0.240 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 250 | 0.220 |
Why?
|
| Female | 25 | 2024 | 65562 | 0.220 |
Why?
|
| Endometrium | 3 | 2009 | 276 | 0.220 |
Why?
|
| Progesterone | 1 | 2006 | 624 | 0.210 |
Why?
|
| Teratoma | 1 | 2004 | 123 | 0.210 |
Why?
|
| General Surgery | 1 | 2004 | 203 | 0.200 |
Why?
|
| Disabled Persons | 1 | 2003 | 99 | 0.190 |
Why?
|
| Fellowships and Scholarships | 1 | 2004 | 271 | 0.190 |
Why?
|
| Menorrhagia | 1 | 2001 | 74 | 0.180 |
Why?
|
| Internship and Residency | 2 | 2014 | 1159 | 0.170 |
Why?
|
| Uterus | 1 | 2004 | 594 | 0.170 |
Why?
|
| Humans | 26 | 2024 | 123180 | 0.160 |
Why?
|
| Catheter Ablation | 1 | 2001 | 234 | 0.160 |
Why?
|
| Contraindications, Procedure | 1 | 2018 | 4 | 0.150 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2018 | 25 | 0.150 |
Why?
|
| Uterine Myomectomy | 1 | 2017 | 12 | 0.150 |
Why?
|
| History, 19th Century | 1 | 2018 | 115 | 0.140 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 148 | 0.140 |
Why?
|
| Kidney | 1 | 2004 | 1335 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2018 | 269 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 120 | 0.130 |
Why?
|
| History, 20th Century | 1 | 2018 | 381 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2003 | 1047 | 0.130 |
Why?
|
| Hand-Assisted Laparoscopy | 1 | 2015 | 3 | 0.130 |
Why?
|
| Adolescent | 9 | 2009 | 19111 | 0.120 |
Why?
|
| Uterine Diseases | 1 | 2015 | 33 | 0.120 |
Why?
|
| Sarcoma | 1 | 2017 | 194 | 0.120 |
Why?
|
| Contraceptives, Oral | 2 | 2007 | 38 | 0.120 |
Why?
|
| Private Practice | 1 | 2015 | 22 | 0.120 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2015 | 28 | 0.120 |
Why?
|
| Blood Loss, Surgical | 1 | 2015 | 147 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 138 | 0.110 |
Why?
|
| Patient Safety | 1 | 2018 | 395 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 384 | 0.100 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2012 | 2 | 0.100 |
Why?
|
| United States | 3 | 2018 | 10660 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2012 | 7 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2018 | 3327 | 0.100 |
Why?
|
| Patch Tests | 1 | 2011 | 6 | 0.100 |
Why?
|
| Obstetrics | 1 | 2014 | 233 | 0.090 |
Why?
|
| Administration, Intravaginal | 2 | 2009 | 8 | 0.090 |
Why?
|
| Uterine Artery Embolization | 1 | 2010 | 5 | 0.090 |
Why?
|
| Colposcopy | 1 | 2009 | 13 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1876 | 0.080 |
Why?
|
| Device Removal | 1 | 2011 | 222 | 0.080 |
Why?
|
| Length of Stay | 1 | 2015 | 1288 | 0.080 |
Why?
|
| Misoprostol | 1 | 2009 | 28 | 0.080 |
Why?
|
| Oxytocics | 1 | 2009 | 29 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2009 | 69 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2018 | 12142 | 0.080 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2007 | 6 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 973 | 0.070 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 61 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2009 | 3547 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2018 | 16062 | 0.070 |
Why?
|
| Endometriosis | 1 | 2009 | 185 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 476 | 0.070 |
Why?
|
| Patient Selection | 1 | 2010 | 683 | 0.070 |
Why?
|
| Pelvis | 1 | 2006 | 68 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2007 | 667 | 0.060 |
Why?
|
| Adult | 7 | 2018 | 29032 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 822 | 0.060 |
Why?
|
| Reproductive Behavior | 1 | 2003 | 7 | 0.050 |
Why?
|
| Ethics | 1 | 2003 | 23 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2006 | 377 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2004 | 1213 | 0.050 |
Why?
|
| Ovary | 1 | 2006 | 389 | 0.050 |
Why?
|
| Vaginal Neoplasms | 1 | 2003 | 14 | 0.050 |
Why?
|
| Laparotomy | 1 | 2004 | 135 | 0.050 |
Why?
|
| Endoscopy | 1 | 2004 | 282 | 0.050 |
Why?
|
| Christianity | 1 | 2001 | 14 | 0.050 |
Why?
|
| Religion and Medicine | 1 | 2001 | 24 | 0.050 |
Why?
|
| Middle Aged | 5 | 2018 | 26015 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 1115 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2010 | 4703 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2003 | 200 | 0.040 |
Why?
|
| Texas | 2 | 2012 | 3565 | 0.040 |
Why?
|
| Sacrum | 1 | 2018 | 29 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 1660 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2018 | 196 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2056 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 3670 | 0.030 |
Why?
|
| Operative Time | 1 | 2015 | 161 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 412 | 0.030 |
Why?
|
| Accreditation | 1 | 2014 | 81 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 175 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2001 | 865 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 2850 | 0.030 |
Why?
|
| Child | 2 | 2004 | 24247 | 0.030 |
Why?
|
| Maryland | 1 | 2012 | 28 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 756 | 0.030 |
Why?
|
| Terbutaline | 1 | 1992 | 6 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 5040 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 1992 | 85 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 230 | 0.020 |
Why?
|
| Dysmenorrhea | 1 | 2009 | 14 | 0.020 |
Why?
|
| Pelvic Pain | 1 | 2009 | 27 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 361 | 0.020 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 29 | 0.020 |
Why?
|
| Dilatation | 1 | 2009 | 68 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2009 | 48 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 1548 | 0.020 |
Why?
|
| Ribonucleosides | 1 | 1988 | 15 | 0.020 |
Why?
|
| Amantadine | 1 | 1988 | 10 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 240 | 0.020 |
Why?
|
| Ribavirin | 1 | 1988 | 79 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6375 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 348 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2113 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 237 | 0.020 |
Why?
|
| Pregnancy | 3 | 2014 | 7146 | 0.020 |
Why?
|
| Reoperation | 1 | 2009 | 818 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 6221 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1988 | 438 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3015 | 0.010 |
Why?
|
| Ameloblastoma | 1 | 1982 | 3 | 0.010 |
Why?
|
| Mandibular Neoplasms | 1 | 1982 | 8 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1988 | 374 | 0.010 |
Why?
|
| Influenza, Human | 1 | 1988 | 651 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 6029 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 19108 | 0.010 |
Why?
|
| Male | 1 | 2004 | 60173 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1982 | 1593 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1992 | 33 | 0.010 |
Why?
|
| Parity | 1 | 1992 | 78 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1992 | 50 | 0.010 |
Why?
|
| Gestational Age | 1 | 1992 | 1139 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2003 | 13904 | 0.000 |
Why?
|
| Influenza A virus | 1 | 1988 | 138 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1988 | 600 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1988 | 1139 | 0.000 |
Why?
|
| Hypercalcemia | 1 | 1982 | 39 | 0.000 |
Why?
|
| Prognosis | 1 | 1992 | 4512 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1988 | 8115 | 0.000 |
Why?
|